Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy. Cohorts of a minimum of five patients each were treated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback